	Correction to: Amino acid-based enteral nutrition is effective for pediatric Crohn's disease: a multicenter prospective study. Gastroenterol Rep (Oxf) PMID: 39723428 [PubMed]
	Comprehensive plasma metabolomics analysis of berberine treatment in ulcerative colitis rats by LC-MS/MS. Front Chem Feng B, Su L, Yang Y, Liu R, Zhang Y, Xin L, Wang L, Yang Z, Wei X, Chen Q. PMID: 39722837 [PubMed]
	Cannabis sativa alleviates experimentally acetic acid- induced ulcerative colitis in rats: targeting CB1/SIRT/MAPK signaling pathways. Immunopharmacol Immunotoxicol Elgohary R, Omara EA, Salama A. PMID: 39721800 [PubMed - as supplied by publisher]
	Selective IgA Deficiency and Aseptic Liver Abscess as Initial Indicators of Crohn's Disease in a Young Woman: A Case Study. Am J Case Rep Amiel A, Van Gucht T, Bolliet M, Aussenac-Belle L, David P, Plastaras L, Martinot M. PMID: 39718979 [PubMed - indexed for MEDLINE]
	Developing and Externally Validating a Simple Index Based on the Nonlinear Relationship of Fecal Calprotectin and Long-Term Outcomes in Ulcerative Colitis. J Inflamm Res Zheng J, Zheng D, Fan Z, Li L, Chen R, Zhang S. PMID: 39717662 [PubMed]
	UDP-glucuronosyltransferases 2A3 as a biomarker for ulcerative colitis and colon cancer. Front Genet Chen H. PMID: 39717480 [PubMed]
	Characteristics of Pediatric Ulcerative Colitis at Diagnosis in Korea: Results From a Multicenter, Registry-Based, Inception Cohort Study. J Korean Med Sci Lim JG, Kang B, Oh SH, Ryoo E, Kim YB, Choe YH, Lee YJ, Shin M, Yang HR, Kim SC, Lee YM, Koh H, Park JS, Choi SY, Jeong SJ, Lee Y, Chang JY, Kim TH, Shim JO, Moon JS. PMID: 39716861 [PubMed - indexed for MEDLINE]
	[Efficient treatment of mild Crohn's disease and mild ulcerative colitis]. Inn Med (Heidelb) Rogler G. PMID: 39715834 [PubMed - as supplied by publisher]
	Common diagnostic biomarkers and molecular mechanisms of Helicobacter pylori infection and inflammatory bowel disease. Front Immunol Zhang M, Liu T, Luo L, Zhang Y, Chen Q, Wang F, Xie Y. PMID: 39712025 [PubMed - indexed for MEDLINE]
	Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management. Therap Adv Gastroenterol Bertin L, Crepaldi M, Zanconato M, Lorenzon G, Maniero D, de Barba C, Bonazzi E, Facchin S, Scarpa M, Ruffolo C, Angriman I, Buda A, Zingone F, Barberio B, Savarino EV. PMID: 39711916 [PubMed]
	Clinical decision support tool-guided, selective intensive induction strategy of ustekinumab in patients with Crohn's disease: A multicenter cohort study. J Dig Dis Li Q, Tang J, Huang ZP, Shi LS, Lyu XP, Chen XM, Chen WK, Xun AY, Guo Q, Li M, Gao X, Chao K. PMID: 39710431 [PubMed - as supplied by publisher]
	Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study. Intest Res Gilmore R, Fernandes R, Hartley I, Arzivian A, Leong R, Andrew B, Vasudevan A, Greeve T, Moore GT, Kim S, Lightowler D, Singh A, Mahy G, Mithanthaya A, Venugopaul K, Han S, Bryant R, West J, Segal J, Christensen B, Corte C, Ding N, An YK, Begun J. PMID: 39709985 [PubMed - as supplied by publisher]
	Extraction of American ginseng polysaccharide by ultrasound-assisted deep eutectic solvents-based three-phase partitioning: Process optimization, structural characterization, and anti-ulcerative colitis study. Ultrason Sonochem Wu Z, Li C, Li J, Wang T, Li M, Zhao L, Ye H, Chen J, Zan J, Song L, Zhang Q, Zhang S. PMID: 39709739 [PubMed - as supplied by publisher]
	Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti-Tumour Necrosis Factor-Î± in Patients With Crohn's Disease: A Systematic Literature Review and Meta-Analysis. United European Gastroenterol J Armuzzi A, Vermeire S, Chaparro M, Biedermann P, Brown R, McStravick M, Meyer M, Schreiber S. PMID: 39707930 [PubMed - as supplied by publisher]
	Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies. Lancet Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A, QUASAR Study Group. PMID: 39706209 [PubMed - as supplied by publisher]
	Predictive value of three nutritional indexes for disease activity in patients with inflammatory bowel disease. Ann Med Chen Z, Zeng L, Cai W, Song X, Xu Q, Xu J, Zhao L, Zeng Y, Zhang X, Wu X, Zhou R, Ying H, Ying K, Chen Y, Yu F. PMID: 39705015 [PubMed - indexed for MEDLINE]
	Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review). Int J Mol Med Qiu W, Akanyibah FA, Xia Y, Ocansey DKW, Mao F, Liang Y. PMID: 39704210 [PubMed - indexed for MEDLINE]
	C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn's Disease. Int J Gen Med Hu H, He R, Liu M, Zhou H, Tan L, Ai Q, Wang Q, Zeng L, Qu W. PMID: 39703796 [PubMed]
	Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn's Disease. Crohns Colitis 360 Rosenfeld S, Clark-Snustad K, Kamp KJ, Jacobs J, Barahimi M, Harper J, Lee SD. PMID: 39703698 [PubMed]
	Synergistic Benefits of Dietary Strategies in the Management of IBD. Curr Gastroenterol Rep Dryden GW, Dryden SM. PMID: 39702516 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 52373

Page 1 of 2619



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy